ACH
Accendra Health, Inc.
NYSE · USHealthcareMedical - Distribution
$3.32-4.32%
Price as of Jul 20, 2026
ACH financials
Accendra Health, Inc. financial statements
Annual and quarterly income statement, balance sheet and cash-flow history. On small screens, start with four periods and expand the table when needed.
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $2.8B | $10.7B | $10.3B | $10.0B |
| Cost of revenue | $1.5B | $8.5B | $8.2B | $8.1B |
| Gross profit | $1.3B | $2.2B | $2.1B | $1.8B |
| Operating expenses | $1.1B | $2.4B | $2.0B | $1.7B |
| Operating income | $221.7M | -$207.8M | $104.5M | $142.9M |
| Net income | -$1.1B | -$362.7M | -$41.3M | $22.4M |
| EBITDA | $219.8M | $51.2M | $390.6M | $368.4M |
| Basic EPS | $-14.31 | $-4.73 | $-0.54 | $0.30 |
| Diluted EPS | $-14.31 | $-4.73 | $-0.54 | $0.29 |
| Balance sheet | ||||
| Cash & equivalents | $282.0M | $49.4M | $243.0M | $69.5M |
| Total assets | $2.5B | $4.7B | $5.1B | $5.4B |
| Total liabilities | $2.9B | $4.1B | $4.2B | $4.4B |
| Stockholders’ equity | -$461.0M | $565.2M | $924.2M | $945.6M |
| Total debt | $2.2B | $2.1B | $2.4B | $2.8B |
| Net debt | $2.0B | $2.1B | $2.2B | $2.7B |
| Cash flow | ||||
| Operating cash flow | -$101.8M | $161.5M | $740.7M | $325.0M |
| Capital expenditure | -$201.3M | -$228.2M | -$207.9M | -$166.6M |
| Free cash flow | -$303.1M | -$66.7M | $532.8M | $158.4M |
| Dividends paid | $0.00 | $0.00 | $0.00 | $0.00 |
| Share repurchases | -$10.2M | $0.00 | $0.00 | $0.00 |